Phase 1 Hypogonadism Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Completed
Phase 1
Topical estradiol add-back in hypogonadal men: dose-finding study
Prostate CancerHypogonadism
University of Melbourne36 enrolled2 locationsACTRN12616000373471
Completed
Phase 1
A pharmacokinetic study to assess the effect of two different formulations of Testosterone Metered Dose (MD) Lotion on the pharmacokinetics of testosterone in hypogonadism
Hypogonadism
Acrux DDS Pty Ltd12 enrolled1 locationACTRN12605000528651
Completed
Phase 1
A pharmacokinetic phase I study to assess the effect of different application sites on the pharmacokinetics of testosterone from a Testosterone Metered Dose (MD) Lotion in hypogonadism.
Hypogonadism
Acrux DDS Pty Ltd12 enrolled1 locationACTRN12605000518662
Completed
Phase 1
A randomised, two-way crossover study to compare the pharmacokinetics of testosterone following application of a Testosterone Metered Dose (MD) lotion or AndroGel in men with low serum testosterone
Hypogonadism
Acrux DDS Pty Ltd6 enrolled1 locationACTRN12605000517673